{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:03:02Z","timestamp":1792789382850,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00467-020-04779-x","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T15:05:03Z","timestamp":1605884703000},"page":"1719-1730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mechanisms and management of edema in pediatric nephrotic syndrome"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1550-5055","authenticated-orcid":false,"given":"Mahmoud","family":"Kallash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Mahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"4779_CR1","first-page":"S118","volume":"59","author":"G Eknoyan","year":"1997","unstructured":"Eknoyan G (1997) A history of edema and its management. Kidney Int Suppl 59:S118\u2013S126","journal-title":"Kidney Int Suppl"},{"key":"4779_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fped.2016.00056","volume":"4","author":"A Pal","year":"2016","unstructured":"Pal A, Kaskel F (2016) History of nephrotic syndrome and evolution of its treatment. Front Pediatr 4:56. https:\/\/doi.org\/10.3389\/fped.2016.00056","journal-title":"Front Pediatr"},{"key":"4779_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1477-7525-11-30","volume":"11","author":"DS Gipson","year":"2013","unstructured":"Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Plattner BW, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA (2013) Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes 11:30. https:\/\/doi.org\/10.1186\/1477-7525-11-30","journal-title":"Health Qual Life Outcomes"},{"key":"4779_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00467-015-3074-x","volume":"30","author":"DT Selewski","year":"2015","unstructured":"Selewski DT, Troost JP, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Song PX, Reeve BB, DeWalt DA, Gipson DS (2015) The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 30:1467\u20131476. https:\/\/doi.org\/10.1007\/s00467-015-3074-x","journal-title":"Pediatr Nephrol"},{"key":"4779_CR5","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.2215\/CJN.06620615","volume":"10","author":"MN Rheault","year":"2015","unstructured":"Rheault MN, Zhang L, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D'Alessandri-Silva C, De Jesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Carpenter SL, Kerlin BA, Smoyer WE, Midwest Pediatric Nephrology Consortium (2015) AKI in children hospitalized with nephrotic syndrome. Clin J Am Soc Nephrol 10:2110\u20132118. https:\/\/doi.org\/10.2215\/CJN.06620615","journal-title":"Clin J Am Soc Nephrol"},{"key":"4779_CR6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.kint.2018.04.024","volume":"94","author":"A Meyrier","year":"2018","unstructured":"Meyrier A, Niaudet P (2018) Acute kidney injury complicating Nephrotic syndrome of minimal change disease. Kidney Int 94:861\u2013869","journal-title":"Kidney Int"},{"key":"4779_CR7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13312-019-1483-9","volume":"56","author":"BS Prasad","year":"2019","unstructured":"Prasad BS, Kumar M, Dabas A, Mishra K (2019) Profile of acute kidney injury in hospitalized children with idiopathic nephrotic syndrome. Indian Pediatr 56:119\u2013122","journal-title":"Indian Pediatr"},{"key":"4779_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fped.2015.00111","volume":"3","author":"D Ellis","year":"2015","unstructured":"Ellis D (2015) Pathophysiology, evaluation, and management of edema in childhood nephrotic syndrome. Front Pediatr 3:111. https:\/\/doi.org\/10.3389\/fped.2015.00111","journal-title":"Front Pediatr"},{"key":"4779_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ki.1994.33","volume":"45","author":"MH Humphreys","year":"1994","unstructured":"Humphreys MH (1994) Mechanisms and management of nephrotic edema. Kidney Int 45:266\u2013281. https:\/\/doi.org\/10.1038\/ki.1994.33","journal-title":"Kidney Int"},{"key":"4779_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/00365518209168064","volume":"42","author":"H Noddeland","year":"1982","unstructured":"Noddeland H, Riisnes SM, Fadnes HO (1982) Interstitial fluid colloid osmotic and hydrostatic pressures in subcutaneous tissue of patients with nephrotic syndrome. Scand J Clin Lab Invest 42:139\u2013146","journal-title":"Scand J Clin Lab Invest"},{"key":"4779_CR11","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00467-013-2435-6","volume":"28","author":"D Bockenhauer","year":"2013","unstructured":"Bockenhauer D (2013) Over- or underfill: not all nephrotic states are created equal. Pediatr Nephrol 28:1153\u20131156. https:\/\/doi.org\/10.1007\/s00467-013-2435-6","journal-title":"Pediatr Nephrol"},{"key":"4779_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ki.2012.180","volume":"82","author":"EC Siddall","year":"2012","unstructured":"Siddall EC, Radhakrishnan J (2012) The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int 82:635\u2013642. https:\/\/doi.org\/10.1038\/ki.2012.180","journal-title":"Kidney Int"},{"key":"4779_CR13","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3389\/fphys.2018.01868","volume":"9","author":"S Gupta","year":"2019","unstructured":"Gupta S, Pepper RJ, Ashman N, Walsh SB (2019) Nephrotic syndrome: oedema formation and its treatment with diuretics. Front Physiol 9:1868","journal-title":"Front Physiol"},{"key":"4779_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/0002-9343(79)90782-4","volume":"67","author":"EJ Dorhout","year":"1979","unstructured":"Dorhout EJ, Roos JC, Boer P, Yoe OH, Simatupang TA (1979) Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am J Med 67:378\u2013384. https:\/\/doi.org\/10.1016\/0002-9343(79)90782-4","journal-title":"Am J Med"},{"key":"4779_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.7326\/0003-4819-91-5-688","volume":"91","author":"JI Meltzer","year":"1979","unstructured":"Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S (1979) Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med 91:688\u2013696. https:\/\/doi.org\/10.7326\/0003-4819-91-5-688","journal-title":"Ann Intern Med"},{"key":"4779_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI110756","volume":"71","author":"I Ichikawa","year":"1983","unstructured":"Ichikawa I, Rennke HG, Hoyer JR, Badr KF, Schor N, Troy JL, Lechene CP, Brenner BM (1983) Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 71:91\u2013103","journal-title":"J Clin Invest"},{"key":"4779_CR17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/cs0800599","volume":"80","author":"B Vogt","year":"1991","unstructured":"Vogt B, Favre H (1991) Na+,K(+)-ATPase activity and hormones in single nephron segments from nephrotic rats. Clin Sci (Lond) 80:599\u2013604","journal-title":"Clin Sci (Lond)"},{"key":"4779_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3906\/sag-1312-130","volume":"45","author":"MA Buyukavci","year":"2015","unstructured":"Buyukavci MA, Civilibal M, Elevli M, Selcuk Duru HN (2015) Hypo- and hypervolemic edema in children with steroid sensitive nephrotic syndrome. Turk J Med Sci 45:178\u2013183","journal-title":"Turk J Med Sci"},{"key":"4779_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/0971-4065.83030","volume":"21","author":"AA Iyengar","year":"2011","unstructured":"Iyengar AA, Kamath N, Vasudevan A, Phadke KD (2011) Urinary indices during relapse of childhood nephrotic syndrome. Indian J Nephrol 21:172\u2013176. https:\/\/doi.org\/10.4103\/0971-4065.83030","journal-title":"Indian J Nephrol"},{"key":"4779_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/IJNRD.S27332","volume":"5","author":"H Lu","year":"2012","unstructured":"Lu H, Kapur G, Mattoo TK, Lyman WD (2012) Hypoxia decreases podocyte expression of slit diaphragm proteins. Int J Nephrol Renov Dis 5:101\u2013107. https:\/\/doi.org\/10.2147\/IJNRD.S27332","journal-title":"Int J Nephrol Renov Dis"},{"key":"4779_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1681\/ASN.2008040364","volume":"20","author":"P Svenningsen","year":"2009","unstructured":"Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skott O (2009) Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 20:299\u2013310. https:\/\/doi.org\/10.1681\/ASN.2008040364","journal-title":"J Am Soc Nephrol"},{"key":"4779_CR22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1681\/ASN.V123598","volume":"12","author":"G Desch\u00eanes","year":"2001","unstructured":"Desch\u00eanes G, Wittner M, Stefano A, Jounier S, Doucet A (2001) Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy. J Am Soc Nephrol 12:598\u2013601","journal-title":"J Am Soc Nephrol"},{"key":"4779_CR23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.V114604","volume":"11","author":"G Deschenes","year":"2000","unstructured":"Deschenes G, Doucet A (2000) Collecting duct (Na+\/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol 11:604\u2013615","journal-title":"J Am Soc Nephrol"},{"issue":"3 Suppl 1","key":"4779_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/SHK.0000000000000666","volume":"46","author":"MA Kottke","year":"2016","unstructured":"Kottke MA, Walters TJ (2016) Where's the leak in vascular barriers? A review. Shock 46(3 Suppl 1):20\u201336. https:\/\/doi.org\/10.1097\/SHK.0000000000000666","journal-title":"Shock"},{"key":"4779_CR25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMra1208627","volume":"369","author":"JA Myburgh","year":"2013","unstructured":"Myburgh JA, Mythen MG (2013) Resuscitation fluids. N Engl J Med 369:1243\u20131251","journal-title":"N Engl J Med"},{"key":"4779_CR26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/SHK.0000000000000513","volume":"45","author":"AZ Chignalia","year":"2016","unstructured":"Chignalia AZ, Yetimakman F, Christiaans SC, Unal S, Bayrakci B, Wagener BM, Russell RT, Kerby JD, Pittet JF, Dull RO (2016) The glycocalyx and trauma: a review. Shock 45:338\u2013348","journal-title":"Shock"},{"key":"4779_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1079\/BJN19790086","volume":"42","author":"M Fiorotto","year":"1979","unstructured":"Fiorotto M, Coward WA (1979) Pathogenesis of oedema in protein-energy malnutrition: the significance of plasma colloid osmotic pressure. Br J Nutr 42:21\u201331","journal-title":"Br J Nutr"},{"key":"4779_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/ki.1984.176","volume":"26","author":"AB Geers","year":"1984","unstructured":"Geers AB, Koomans HA, Roos JC, Boer P, Dorhout Mees EJ (1984) Functional relationships in the nephrotic syndrome. Kidney Int 26:324\u2013330. https:\/\/doi.org\/10.1038\/ki.1984.176","journal-title":"Kidney Int"},{"key":"4779_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ki.2012.180","volume":"82","author":"EC Siddall","year":"2012","unstructured":"Siddall EC, Radhakrishnan J (2012) The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int 82:635\u2013642. https:\/\/doi.org\/10.1038\/ki.2012.180","journal-title":"Kidney Int"},{"key":"4779_CR30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1681\/ASN.V102323","volume":"10","author":"JG Vande Walle","year":"1999","unstructured":"Vande Walle JG, Donckerwolcke RA, Koomans HA (1999) Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol 10:323\u2013331","journal-title":"J Am Soc Nephrol"},{"key":"4779_CR31","first-page":"F298","volume":"232","author":"MD Johnson","year":"1977","unstructured":"Johnson MD, Malvin RL (1977) Stimulation of renal sodium reabsorption by angiotensin II. Am J Phys 232:F298\u2013F306","journal-title":"Am J Phys"},{"key":"4779_CR32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1126\/science.2463673","volume":"243","author":"DB Light","year":"1989","unstructured":"Light DB, Schwiebert EM, Karlson KH, Stanton BA (1989) Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science 243:383\u2013385","journal-title":"Science"},{"key":"4779_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ki.1989.161","volume":"36","author":"N Perico","year":"1989","unstructured":"Perico N, Delaini F, Lupini C, Benigni A, Galbusera M, Boccardo P, Remuzzi G (1989) Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. Kidney Int 36:57\u201364. https:\/\/doi.org\/10.1038\/ki.1989.161","journal-title":"Kidney Int"},{"key":"4779_CR34","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1172\/JCI115995","volume":"90","author":"JP Valentin","year":"1992","unstructured":"Valentin JP, Qiu C, Muldowney WP, Ying WZ, Gardner DG, Humphreys MH (1992) Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome. J Clin Invest 90:1302\u20131312. https:\/\/doi.org\/10.1172\/JCI115995","journal-title":"J Clin Invest"},{"key":"4779_CR35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/cs0770445","volume":"77","author":"H Mansy","year":"1989","unstructured":"Mansy H, Goodship TH, Tapson JS, Hartley GH, Keavey P, Wilkinson R (1989) Effect of a high protein diet in patients with the nephrotic syndrome. Clin Sci (Lond) 77:445\u2013451","journal-title":"Clin Sci (Lond)"},{"key":"4779_CR36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00467-013-2567-8","volume":"29","author":"MA Cadnapaphornchai","year":"2014","unstructured":"Cadnapaphornchai MA, Tkachenko O, Shchekochikhin D, Schrier RW (2014) The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatr Nephrol 29:1159\u20131167","journal-title":"Pediatr Nephrol"},{"key":"4779_CR37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2215\/CJN.04390808","volume":"4","author":"G Kapur","year":"2009","unstructured":"Kapur G, Valentini RP, Imam AA, Mattoo TK (2009) Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study. Clin J Am Soc Nephrol 4:907\u2013913","journal-title":"Clin J Am Soc Nephrol"},{"key":"4779_CR38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2169\/internalmedicine.50.4537","volume":"50","author":"H Matsumoto","year":"2011","unstructured":"Matsumoto H, Miyaoka Y, Okada T, Nagaoka Y, Wada T, Gondo A, Esaki S, Hayashi A, Nakao T (2011) Ratio of urinary potassium to urinary sodium and the potassium and edema status in nephrotic syndrome. Intern Med 50:551\u2013555","journal-title":"Intern Med"},{"key":"4779_CR39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5414\/CNP59259","volume":"59","author":"RAMG Donckerwolcke","year":"2003","unstructured":"Donckerwolcke RAMG, France A, Raes A, Vande Walle J (2003) Distal nephron sodium-potassium exchange in children with nephrotic syndrome. Clin Nephrol 59:259\u2013266","journal-title":"Clin Nephrol"},{"key":"4779_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2165\/00003495-199100413-00004","volume":"41","author":"DC Brater","year":"1991","unstructured":"Brater DC (1991) Clinical pharmacology of loop diuretics. Drugs 41:14\u201322. https:\/\/doi.org\/10.2165\/00003495-199100413-00004","journal-title":"Drugs"},{"key":"4779_CR41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00630286","volume":"26","author":"MM Hammarlund","year":"1984","unstructured":"Hammarlund MM, Paalzow LK, Odlind B (1984) Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis. Eur J Clin Pharmacol 26:197\u2013207","journal-title":"Eur J Clin Pharmacol"},{"key":"4779_CR42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/jps.2600711006","volume":"71","author":"ES Waller","year":"1981","unstructured":"Waller ES, Hamilton SF, Massarella JW, Sharanevych MA, Smith RV, Yakatan GJ, Doluisio JT (1981) Disposition and absolute bioavailability of furosemide in healthy males. J Pharm Sci 71:1105\u20131108","journal-title":"J Pharm Sci"},{"key":"4779_CR43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2016.08.027","volume":"69","author":"EJ Hoorn","year":"2017","unstructured":"Hoorn EJ, Ellison DH (2017) Diuretic resistance. Am J Kidney Dis 69:136\u2013142","journal-title":"Am J Kidney Dis"},{"key":"4779_CR44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1527-5299.2003.02399.x","volume":"9","author":"DA Sica","year":"2003","unstructured":"Sica DA (2003) Drug absorption in the management of congestive heart failure: loop diuretics. Congest Heart Fail 9:287\u2013292","journal-title":"Congest Heart Fail"},{"key":"4779_CR45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/cells4040622","volume":"4","author":"M Duffy","year":"2015","unstructured":"Duffy M, Jain S, Harrell N, Kothari N, Reddi AS (2015) Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies. Cells 4:622\u2013630","journal-title":"Cells"},{"key":"4779_CR46","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1681\/ASN.V1161100","volume":"11","author":"R Agarwal","year":"2000","unstructured":"Agarwal R, Gorski JC, Sundblad K, Brater DC (2000) Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. J Am Soc Nephrol 11:1100\u20131105","journal-title":"J Am Soc Nephrol"},{"key":"4779_CR47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ki.1984.153","volume":"26","author":"DC Brater","year":"1984","unstructured":"Brater DC, Day B, Burdette A, Anderson S (1984) Bumetanide and furosemide in heart failure. Kidney Int 26:183\u2013189","journal-title":"Kidney Int"},{"key":"4779_CR48","first-page":"489","volume":"16","author":"K Lau","year":"1976","unstructured":"Lau K, DeFronzo R, Morrison G, Rascoff J, Goldberg M, Agus ZS (1976) Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide. J Clin Pharmacol 16:489\u2013497","journal-title":"J Clin Pharmacol"},{"key":"4779_CR49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ki.1985.154","volume":"28","author":"M Hropot","year":"1985","unstructured":"Hropot M, Fowler N, Karlmark B, Giebisch G (1985) Tubular action of diuretics: distal effects on electrolyte transport and acidification. Kidney Int 28:477\u2013489","journal-title":"Kidney Int"},{"key":"4779_CR50","first-page":"6","volume":"180","author":"WN Suki","year":"1972","unstructured":"Suki WN, Dawoud F, Eknoyan G, Martinez-Maldonado M (1972) Effects of metolazone on renal function in normal man. J Pharmacol Exp Ther 180:6\u201312","journal-title":"J Pharmacol Exp Ther"},{"key":"4779_CR51","first-page":"136","volume":"10","author":"PA Preisig","year":"1987","unstructured":"Preisig PA, Toto RD, Alpern RJ (1987) Carbonic anhydrase inhibitors. Renal Physiol 10:136\u2013159","journal-title":"Renal Physiol"},{"key":"4779_CR52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/j.1875-9114.1981.tb02539.x","volume":"1","author":"DG Vidt","year":"1981","unstructured":"Vidt DG (1981) Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic. Pharmacotherapy 1:179\u2013187","journal-title":"Pharmacotherapy"},{"key":"4779_CR53","doi-asserted-by":"crossref","first-page":"e13743","DOI":"10.14814\/phy2.13743","volume":"6","author":"GR Hinrichs","year":"2018","unstructured":"Hinrichs GR, Mortensen LA, Jensen BL, Bistrup C (2018) Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report. Phys Rep 6:e13743","journal-title":"Phys Rep"},{"key":"4779_CR54","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/ki.1997.203","volume":"51","author":"H Peters","year":"1997","unstructured":"Peters H, Noble NA (1997) Angiotensin II and L-arginine in tissue fibrosis: more than blood pressure. Kidney Int 51:1481\u20131486. https:\/\/doi.org\/10.1038\/ki.1997.203","journal-title":"Kidney Int"},{"key":"4779_CR55","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/ajkd.2000.19078","volume":"36","author":"GT Shin","year":"2000","unstructured":"Shin GT, Kim SJ, Ma KA, Kim HS, Kim D (2000) ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans. Am J Kidney Dis 36:894\u2013902","journal-title":"Am J Kidney Dis"},{"key":"4779_CR56","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.1981.00340100031012","volume":"141","author":"GM Berlyne","year":"1981","unstructured":"Berlyne GM, Brown C, Adler A, Feinroth MV, Feinroth M, Hirsch S, Friedman EA (1981) Water immersion in nephrotic syndrome. Arch Intern Med 141:1275\u20131278","journal-title":"Arch Intern Med"},{"key":"4779_CR57","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cardfail.2005.03.009","volume":"11","author":"M Gheorghiade","year":"2005","unstructured":"Gheorghiade M, Orlandi C, Burnett JC, Demets D, Grinfeld L, Maggioni A, Swedberg K, Udelson JE, Zannad F, Zimmer C, Konstam MA (2005) Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: outcome study with tolvaptan (EVEREST). J Card Fail 11:260\u2013269","journal-title":"J Card Fail"},{"key":"4779_CR58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00535-010-0240-6","volume":"45","author":"K Okita","year":"2010","unstructured":"Okita K, Sakaida I, Okada M, Kaneko A, Chayama K, Kato M, Sata M, Yoshihara H, Ono N, Murawaki Y (2010) A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis. J Gastroenterol 45:979\u2013987","journal-title":"J Gastroenterol"},{"key":"4779_CR59","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/jcph.342","volume":"54","author":"S Chen","year":"2014","unstructured":"Chen S, Zhao JJ, Tong NW, Guo XH, Qiu MC, Yang GY, Liu ZM, Ma JH, Zhang ZW, Gu F (2014) Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH. J Clin Pharmacol 54:1362\u20131367","journal-title":"J Clin Pharmacol"},{"key":"4779_CR60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2466-13-55","volume":"13","author":"C Petereit","year":"2013","unstructured":"Petereit C, Zaba O, Teber I, Luders H, Grohe C (2013) A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan. BMC Pulm Med 13:55","journal-title":"BMC Pulm Med"},{"key":"4779_CR61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/nep.12348","volume":"20","author":"ES Park","year":"2015","unstructured":"Park ES, Huh YS, Kim GH (2015) Is tolvaptan indicated for refractory oedema in nephrotic syndrome? Nephrology (Carlton) 20:103\u2013106. https:\/\/doi.org\/10.1111\/nep.12348","journal-title":"Nephrology (Carlton)"},{"key":"4779_CR62","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00467-013-2687-1","volume":"29","author":"M Shimizu","year":"2014","unstructured":"Shimizu M, Ishikawa S, Yachi Y, Muraoka M, Tasaki Y, Iwasaki H, Kuroda M, Ohta K, Yachie A (2014) Tolvaptan therapy for massive edema in a patient with nephrotic syndrome. Pediatr Nephrol 29:915\u2013917","journal-title":"Pediatr Nephrol"},{"key":"4779_CR63","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/nep.13390","volume":"23","author":"T Takada","year":"2018","unstructured":"Takada T, Masaki T, Hoshiyama A, Toki T, Kamata Y, Shichiri M (2018) Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide. Nephrology (Carlton) 23:883\u2013886","journal-title":"Nephrology (Carlton)"},{"key":"4779_CR64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2169\/internalmedicine.56.7539","volume":"56","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Nakamura T, Sato E, Ueda Y, Node K (2017) Different effects of tolvaptan in patients with idiopathic membranous nephropathy with nephrotic syndrome. Intern Med 56:191\u2013196","journal-title":"Intern Med"},{"key":"4779_CR65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ki.2015.138","volume":"88","author":"O Cil","year":"2015","unstructured":"Cil O, Esteva-Font C, Tas ST, Su T, Lee S, Anderson MO, Ertunc M, Verkman AS (2015) Salt-sparing diuretic action of a water-soluble urea analog inhibitor of urea transporters UT-A and UT-B in rats. Kidney Int 88:311\u2013320","journal-title":"Kidney Int"},{"key":"4779_CR66","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ki.2013.94","volume":"83","author":"MA Knepper","year":"2013","unstructured":"Knepper MA, Miranda CA (2013) Urea channel inhibitors: a new functional class of aquaretics. Kidney Int 83:991\u2013993","journal-title":"Kidney Int"},{"key":"4779_CR67","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/ijms19041006","volume":"19","author":"Y Chen","year":"2018","unstructured":"Chen Y, Burnett JC (2018) Particulate guanylyl cyclase a\/cGMP signaling pathway in the kidney: physiologic and therapeutic indications. Int J Mol Sci 19:1006. https:\/\/doi.org\/10.3390\/ijms19041006","journal-title":"Int J Mol Sci"},{"key":"4779_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/phar.1548","volume":"35","author":"SS Wilson","year":"2015","unstructured":"Wilson SS, Ayaz SI, Levy PD (2015) Relaxin: a novel agent for the treatment of acute heart failure. Pharmacotherapy 35:315\u2013327. https:\/\/doi.org\/10.1002\/phar.1548","journal-title":"Pharmacotherapy"},{"key":"4779_CR69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2017.05.012","volume":"190","author":"C Gimpelewicz","year":"2017","unstructured":"Gimpelewicz C, Metra M, Cleland JGF, Szecsody P, Chang Wun CC, Boer-Martins L, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang P, Ponikowski P, Severin T, Voors AA, Teerlink JR (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. Am Heart J 190:113\u2013122","journal-title":"Am Heart J"},{"key":"4779_CR70","doi-asserted-by":"crossref","first-page":"F1047","DOI":"10.1152\/ajprenal.00164.2014","volume":"308","author":"F Theilig","year":"2015","unstructured":"Theilig F, Wu Q (2015) ANP-induced signaling cascade and its implications in renal pathophysiology. Am J Physiol Ren Physiol 308:F1047\u2013F1055","journal-title":"Am J Physiol Ren Physiol"},{"key":"4779_CR71","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2169\/internalmedicine.53.1724","volume":"53","author":"K Ueda","year":"2014","unstructured":"Ueda K, Hirahashi J, Seki G, Tanaka M, Kushida N, Takeshima Y, Nishikawa Y, Fujita T, Nangaku M (2014) Successful treatment of acute kidney injury in patients with idiopathic nephrotic syndrome using human atrial natriuretic peptide. Intern Med 53:865\u2013869","journal-title":"Intern Med"},{"key":"4779_CR72","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.pharep.2017.05.010","volume":"69","author":"T Boeing","year":"2017","unstructured":"Boeing T, da Silva LM, Mariott M, Andrade SF, de Souza P (2017) Diuretic and natriuretic effect of luteolin in normotensive and hypertensive rats: role of muscarinic acetylcholine receptors. Pharmacol Rep 69:1121\u20131124. https:\/\/doi.org\/10.1016\/j.pharep.2017.05.010","journal-title":"Pharmacol Rep"},{"key":"4779_CR73","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.biopha.2018.08.045","volume":"107","author":"LNB Mariano","year":"2018","unstructured":"Mariano LNB, Boeing T, da Silva R, Cechinel-Filho V, Niero R, da Silva LM, de Souza P, Andrade SF (2018) Preclinical evaluation of the diuretic and saluretic effects of (-)-epicatechin and the result of its combination with standard diuretics. Biomed Pharmacother 107:520\u2013525","journal-title":"Biomed Pharmacother"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04779-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T19:28:14Z","timestamp":1622662094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4779"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04779-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"10 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}